Comparison of two preemptive treatment strategies of panitumumab mediated skin toxicity and assessment of quality of life in patients with kras-wildtype colorectal cancer.

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

19 Apr 2016 Biomarkers information updated
30 Jul 2013 Planned end date changed from 1 Feb 2013 to 1 Jan 2015 as reported by ClinicalTrials.gov.
17 Aug 2012 Additional lead trial investigator (Kripp M) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com